Stephen R. Brady - Jan 3, 2023 Form 4 Insider Report for Tempest Therapeutics, Inc. (TPST)

Role
Chief Executive Officer, Director
Signature
/s/ Stephen R. Brady
Stock symbol
TPST
Transactions as of
Jan 3, 2023
Transactions value $
$0
Form type
4
Date filed
1/5/2023, 07:00 PM
Previous filing
Jun 22, 2022
Next filing
Jun 15, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TPST Employee Stock Option (right to buy) Award $0 +177K $0.00 177K Jan 3, 2023 Common Stock 177K $1.23 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options vest in a series of 48 equal monthly installments measured from January 3, 2023, subject to the reporting person's continued service.